| Sean Kelly, | |
|
2401 Laura Cir, Papillion, NE 68046-4216 | |
| (402) 250-4804 | |
| Not Available |
| Full Name | Sean Kelly |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 8 Years |
| Location | 2401 Laura Cir, Papillion, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326499088 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 7766 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Nebraska Medical Center | Omaha, NE | Hospital |
| Bellevue Medical Center | Bellevue, NE | Hospital |
| Nebraska Orthopaedic Hospital | Omaha, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unmc Physicians | 6002728391 | 1320 |
News Archive
An exciting new study by researchers at the Universities of Oxford and Edinburgh and published on the preprint server medRxiv* in July 2020 reports that early and stringent government measures in the form of non-pharmaceutical interventions (NPIs) against the spread of COVID-19 results in a significant reduction in the mortality due to this disease. The finding could help shape public health policies in the absence of effective vaccines or therapeutic drugs.
The U.S. Food and Drug Administration today permitted marketing of the first medical device to treat attention deficit hyperactivity disorder.
Researchers have begun screening the first definitive collection of thousands of approved drugs for clinical use against rare and neglected diseases. They are hunting for additional uses of the drugs hoping to find off-label therapies, for some of the 6,000 rare diseases that afflict 25 million Americans.
Cepheid announced today the release of Xpert® Flu/RSV XC, an on-demand molecular test for rapid, accurate and reliable determination of Flu A, Flu B, and differentiation of RSV infection.
The human brain is a constant buzz of activity, with its 86 billion nerve cells (neurons) sending electrical signals from one region of the brain to another. The signals travel along the white matter fibers, a maze of wire-like fibers, ultimately giving rise to all brain functions.
› Verified 5 days ago
| Entity Name | Unmc Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417912114 PECOS PAC ID: 6002728391 Enrollment ID: O20031104000664 |
News Archive
An exciting new study by researchers at the Universities of Oxford and Edinburgh and published on the preprint server medRxiv* in July 2020 reports that early and stringent government measures in the form of non-pharmaceutical interventions (NPIs) against the spread of COVID-19 results in a significant reduction in the mortality due to this disease. The finding could help shape public health policies in the absence of effective vaccines or therapeutic drugs.
The U.S. Food and Drug Administration today permitted marketing of the first medical device to treat attention deficit hyperactivity disorder.
Researchers have begun screening the first definitive collection of thousands of approved drugs for clinical use against rare and neglected diseases. They are hunting for additional uses of the drugs hoping to find off-label therapies, for some of the 6,000 rare diseases that afflict 25 million Americans.
Cepheid announced today the release of Xpert® Flu/RSV XC, an on-demand molecular test for rapid, accurate and reliable determination of Flu A, Flu B, and differentiation of RSV infection.
The human brain is a constant buzz of activity, with its 86 billion nerve cells (neurons) sending electrical signals from one region of the brain to another. The signals travel along the white matter fibers, a maze of wire-like fibers, ultimately giving rise to all brain functions.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sean Kelly, 2401 Laura Cir, Papillion, NE 68046-4216 Ph: () - | Sean Kelly, 2401 Laura Cir, Papillion, NE 68046-4216 Ph: (402) 250-4804 |
News Archive
An exciting new study by researchers at the Universities of Oxford and Edinburgh and published on the preprint server medRxiv* in July 2020 reports that early and stringent government measures in the form of non-pharmaceutical interventions (NPIs) against the spread of COVID-19 results in a significant reduction in the mortality due to this disease. The finding could help shape public health policies in the absence of effective vaccines or therapeutic drugs.
The U.S. Food and Drug Administration today permitted marketing of the first medical device to treat attention deficit hyperactivity disorder.
Researchers have begun screening the first definitive collection of thousands of approved drugs for clinical use against rare and neglected diseases. They are hunting for additional uses of the drugs hoping to find off-label therapies, for some of the 6,000 rare diseases that afflict 25 million Americans.
Cepheid announced today the release of Xpert® Flu/RSV XC, an on-demand molecular test for rapid, accurate and reliable determination of Flu A, Flu B, and differentiation of RSV infection.
The human brain is a constant buzz of activity, with its 86 billion nerve cells (neurons) sending electrical signals from one region of the brain to another. The signals travel along the white matter fibers, a maze of wire-like fibers, ultimately giving rise to all brain functions.
› Verified 5 days ago
Mary Dankof, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 11111 S 84th St, Papillion, NE 68046 Phone: 402-593-3131 Fax: 402-593-3117 | |
Geetha Palaniappan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 Fenwick Dr, Papillion, NE 68046 Phone: 402-593-3141 Fax: 402-593-3145 | |
Dr. Timothy K. Huyck, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 Fenwick Dr, Papillion, NE 68046 Phone: 402-593-3141 | |
Fredrick Schwartz, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 11109 S 84th St, Suite 5800, Papillion, NE 68046 Phone: 402-827-4900 |